Sign Up

Patients’ preferences for ways to communicate benefits of cardiovascular medication

NZ Literature Abstract

posted by Research Admin on 19 April 2011

Authors

Felicity Goodyear-Smith
Timothy Kenealy
Susan Wells
Bruce Arroll
Margaret Horsburgh

Year of Publication

2011

Source

Annals of Family Medicine 9, 121-127

Publication Type

Journal article (peer reviewed)

Publication Status

Completed

Abstract

The authors wanted to determine patients’ willingness to take preventive cardiovascular disease (CVD) medication in relation to their 5-year CVD risk score and modes of communicating benefits of therapy. Study participants were 934 consecutive patients drawn from family practitioners’ waiting rooms in Auckland, who knew their 5-year CVD risk (ranging from 5% to 30%) and who completed a questionnaire asking them to rate how much various modes of communicating the benefits of therapy would encourage them to take medication daily, where the benefits from medication were proportional to their estimated CVD risk score.

Type of Study

Quantitative, Analysis

How to Access

Available free in full text at: http://annfammed.org/cgi/content/abstract/9/2/121

Discussion. 0 comments.